Successful treatment of perioperative very late stent thrombosis with thromboaspiration device.

نویسنده

  • K L Yew
چکیده

I read with interest the article by S Sikdar et al on “Perioperative Very Late Stent Thrombosis treated with Thrombosuction” . The authors highlighted a very pertinent issue regarding the perioperative management conundrum of antiplatelet therapy in the setting of prior coronary stent implantation. Cypher ® (Cordis, Johnson & Johnson, Bridgewater, NJ) is a sirolimus drug eluting stent. As pointed out by the authors, the 2007 Focus Update of American College of Cardiology (ACC)/American Heart Association (AHA) /Society for Cardiovascular Angiography and Interventions (SCAI) recommended at least 3 months of clopidogrel treatment in combination with long term aspirin after sirolimus drug eluting stent (DES) implantation. However, the extended duration of 5 years dual antiplatelet therapy(DAT) has not been well established. We do not know the reason for the patient’s 5 year extended DAT.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Perioperative very late stent thrombosis treated with thrombosuction.

Fig. 1: Left coronary angiogram in Right Anterior Oblique view with caudal tilt showing thrombus inside the Left Anterior Descending ( LAD) stent at diagonal origin .Note the haziness marked by arrow , indicating a filling defect inside the stent . LCX= Left circumflex , LMCA= Left Main Coronary Artery ,OM = Obtuse Marginal. Fig. 2: Post thrombosuction left coronary angiogram in the same view s...

متن کامل

Late thrombosis of a drug-eluting stent presenting in the perioperative period.

DRUG-ELUTING stents (DES) represent the latest percutaneous coronary intervention (PCI) designed to deal with the problem of in-stent restenosis. These stents are impregnated with a drug (sirolimus or paclitaxel) that retards the neointimal proliferation that leads to restenosis. The thrombogenic profile of DES differs from that of bare metal stents. Postprocedure dual antiplatelet therapy (clo...

متن کامل

Perioperative management of antiplatelet therapy in patients with drug-eluting stents

Significant advancements in percutaneous treatment of coronary artery disease have been achieved with the introduction of bare metal stents. They have two major drawbacks: acute/subacute stent thrombosis, successfully managed with antiplatelet therapy immediately after stent implantation; and in-stent restenosis, prevention of which has been achieved with the development of drug-eluting stents....

متن کامل

Drug-Coated Balloon Treatment of Very Late Stent Thrombosis Due to Complicated Neoatherosclerosis

We describe the treatment of a patient presenting with very-late stent thrombosis with the use of a drug-coated balloon. In this patient, optical coherence tomography disclosed that ruptured and complicated neoatherosclerosis was the underlying substrate responsible for the episode of very-late stent thrombosis. The potential use of drug-coated balloons in this unique scenario is discussed.

متن کامل

Two Cases of Cerebral Venous Sinus Thrombosis Successfully Recanalized by the Concomitant Use of an Aspiration through the Guiding Catheter and Stent Thrombectomy Device

Objective: Two cases of cerebral venous sinus thrombosis (CVST) effectively recanalized endovascularly by a combination of thromboaspiration using Cerulean catheter DD6 and stent retriever device are reported. Case Presentations: We endovascularly treated two cases of CVST that presented with progressive vomiting and disturbance of consciousness several days before the diagnosis of occlusion of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Medical journal of Malaysia

دوره 67 3  شماره 

صفحات  -

تاریخ انتشار 2012